K Thomas Bailey's Net Worth

$6.26 Million

Estimate Recalculated May 8, 2024 07:52PM EST

Who is K Thomas Bailey?

K Thomas Bailey has an estimated net worth of $6.26 Million. This is based on reported shares across multiple companies, which include NanoString Technologies Inc, and ANGIOTECH PHARMACEUTICALS INC.

SEC CIK

K Thomas Bailey's CIK is 0001432055

Past Insider Trading and Trends

2021 was K Thomas Bailey's most active year for acquiring shares with 14 total transactions. K Thomas Bailey's most active month to acquire stocks was the month of February. 2021 was K Thomas Bailey's most active year for disposing of shares, totalling 29 transactions. K Thomas Bailey's most active month to dispose stocks was the month of February. 2020 saw K Thomas Bailey paying a total of $506,576.70 for 93,780 shares, this is the most they've acquired in one year. In 2021 K Thomas Bailey cashed out on 99,799 shares for a total of $3,839,960.01, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NanoString Technologies Inc (NSTG) Snapshot price: $0.0801

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+150.42%
182.7K
—
—
304.16K
May 6
Form 4
+61.11%
46.07K
—
—
121.46K
Mar 5
Form 4
+24.84%
15K
$5.76
$86,445.00
75.39K
May 26
Form 4
+18.93%
9.61K
$10.16
-$67,045.84
60.39K
Mar 4 - Mar 6
Form 4
+4.62%
2.24K
$10.39
-$18,795.51
50.77K
Jan 26
Form 4
+150.53%
29.16K
$8.05
$234,746.05
48.53K
Dec 13
Form 4
+20.29%
3.27K
$27.81
-$58,674.88
19.37K
Mar 14 - Mar 15
Form 4
-23.69%
-5.00K
$33.81
-$169,050.00
16.11K
Mar 10
Form 4
+28.61%
4.7K
$33.06
-$101,109.71
21.11K
Mar 6 - Mar 8
Form 4
+163.87%
10.19K
$31.00
-$109,058.00
16.41K
Jan 27
Form 4/A
—
0
—
—
0
Jan 26
Form 4/A
—
0
—
—
0
Jan 27
Form 4
∞
6.22K
$31.99
-$64,075.97
6.22K
Jan 26
Form 4
—
0
$29.30
-$273,647.72
0
Scheduled
Nov 17
Form 4
—
0
$31.92
-$314,812.65
0
Scheduled
Aug 17
Form 4
—
0
$31.48
-$205,254.70
0
Scheduled
May 18
Form 4
-6.01%
-1.16K
$66.32
-$76,997.52
18.16K
Mar 16
Form 4/A
+26.45%
4.04K
$66.32
-$88,537.20
19.32K
Mar 15 - Mar 16
Form 4/A
—
0
—
—
0
Form 4
-100.00%
-18.16K
$38.74
-$1,753,988.37
0
Scheduled
Mar 17
Form 4
+28.87%
4.04K
$66.32
-$88,537.20
18.04K
Mar 15
Form 4
—
0
—
—
0
Mar 11
Form 4
+36.08%
3.71K
$60.33
-$76,981.08
14K
Mar 5 - Mar 9
Form 4
∞
10.29K
$63.59
-$217,668.57
10.29K
Jan 27
Form 4
—
0
$33.07
-$542,851.54
0
Scheduled
Nov 18 - Nov 19
Form 4
—
0
$23.55
-$182,774.98
0
Scheduled
Aug 18
Form 4
-100.00%
-3.26K
$29.17
-$95,104.96
0
Scheduled
Jun 30
Form 4
—
0
$20.01
-$140,683.62
3.26K
Scheduled
May 18
Form 4
∞
3.26K
$19.53
-$41,325.48
3.26K
Mar 16
Form 4
—
0
—
—
0
Mar 12
Form 4
—
0
$19.81
-$184,581.82
0
Scheduled
Mar 10
Form 4
-100.00%
-25.87K
$28.10
-$727,075.64
0
Scheduled
Feb 3
Form 4
∞
25.87K
$30.84
-$281,507.52
25.87K
Jan 16
Form 4
—
0
$15.58
-$88,108.05
0
Scheduled
Nov 12
Form 4
—
0
$16.70
-$608,326.20
0
Scheduled
Aug 6
Form 4
—
0
—
—
0
Mar 25
Form 4
—
0
—
—
0
Jan 16 - Jan 18
Form 3
—
0
—
—
0
No matching records found

ANGIOTECH PHARMACEUTICALS INC No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-100.00%
-30.00K
—
—
0
May 12
Form 4
-100.00%
-30.00K
$1.67
-$50,089.00
0
May 12
Form 4
—
0
—
—
0
Mar 8
Form 4
∞
30K
$1.67
$50,089.00
30K
Aug 17 - Aug 18
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Mar 10
Form 4/A
—
0
—
—
0
Dec 8
Form 4
—
0
—
—
0
Dec 8
Form 3
—
0
—
—
0
No matching records found